A community pharmacy-based cardiovascular risk screening service implemented in Iran

Abstract Background: Cardiovascular disease is a major health concern around the world. Objective: To assess the outcomes and feasibility of a pharmacy-based cardiovascular screening in an urban referral community pharmacy in Iran. Methods: A cross sectional study was conducted in a referral community pharmacy. Subjects aged between 30-75 years without previous diagnose of cardiovascular disease or diabetes were screened. Measurement of all major cardiovascular risk factors, exercise habits, medical conditions, medications, and family history were investigated. Framingham risk score was calculated and high risk individuals were given a clinical summary sheet signed by a clinical pharmacist and were encouraged to follow up with their physician. Subjects were contacted one month after the recruitment period and their adherence to the follow up recommendation was recorded. Results: Data from 287 participants were analyzed and 146 were referred due to at least one abnormal laboratory test. The results showed 26 patients with cardiovascular disease risk greater than 20%, 32 high systolic blood pressure, 22 high diastolic blood pressures, 50 high total cholesterol levels, 108 low HDL-C levels, and 22 abnormal blood glucose levels. Approximately half of the individuals who received a follow up recommendation had made an appointment with their physician. Overall, 15.9% of the individuals received medications and 15.9% received appropriate advice for risk factor modification. Moreover, 7.5% were under evaluation by a physician. Conclusion: A screening program in a community pharmacy has the potential to identify patients with elevated cardiovascular risk factor. A plan for increased patient adherence to follow up recommendations is required.

Saved in:
Bibliographic Details
Main Authors: Jahangard-Rafsanjani,Zahra, Hakimzadeh,Negar, Sarayani,Amir, Najafi,Sheyda, Heidari,Kazem, Javadi,Mohammad R., Hadjibabaie,Molouk, Gholami,Kheirollah
Format: Digital revista
Language:English
Published: Centro de Investigaciones y Publicaciones Farmacéuticas 2017
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2017000200006
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1885-642X2017000200006
record_format ojs
spelling oai:scielo:S1885-642X20170002000062021-03-29A community pharmacy-based cardiovascular risk screening service implemented in IranJahangard-Rafsanjani,ZahraHakimzadeh,NegarSarayani,AmirNajafi,SheydaHeidari,KazemJavadi,Mohammad R.Hadjibabaie,MoloukGholami,Kheirollah Mass Screening Community Pharmacy Services Pharmacies Cardiovascular Diseases Diagnostic Techniques Cardiovascular Iran Abstract Background: Cardiovascular disease is a major health concern around the world. Objective: To assess the outcomes and feasibility of a pharmacy-based cardiovascular screening in an urban referral community pharmacy in Iran. Methods: A cross sectional study was conducted in a referral community pharmacy. Subjects aged between 30-75 years without previous diagnose of cardiovascular disease or diabetes were screened. Measurement of all major cardiovascular risk factors, exercise habits, medical conditions, medications, and family history were investigated. Framingham risk score was calculated and high risk individuals were given a clinical summary sheet signed by a clinical pharmacist and were encouraged to follow up with their physician. Subjects were contacted one month after the recruitment period and their adherence to the follow up recommendation was recorded. Results: Data from 287 participants were analyzed and 146 were referred due to at least one abnormal laboratory test. The results showed 26 patients with cardiovascular disease risk greater than 20%, 32 high systolic blood pressure, 22 high diastolic blood pressures, 50 high total cholesterol levels, 108 low HDL-C levels, and 22 abnormal blood glucose levels. Approximately half of the individuals who received a follow up recommendation had made an appointment with their physician. Overall, 15.9% of the individuals received medications and 15.9% received appropriate advice for risk factor modification. Moreover, 7.5% were under evaluation by a physician. Conclusion: A screening program in a community pharmacy has the potential to identify patients with elevated cardiovascular risk factor. A plan for increased patient adherence to follow up recommendations is required.Centro de Investigaciones y Publicaciones FarmacéuticasPharmacy Practice (Granada) v.15 n.2 20172017-06-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2017000200006en
institution SCIELO
collection OJS
country España
countrycode ES
component Revista
access En linea
databasecode rev-scielo-es
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Jahangard-Rafsanjani,Zahra
Hakimzadeh,Negar
Sarayani,Amir
Najafi,Sheyda
Heidari,Kazem
Javadi,Mohammad R.
Hadjibabaie,Molouk
Gholami,Kheirollah
spellingShingle Jahangard-Rafsanjani,Zahra
Hakimzadeh,Negar
Sarayani,Amir
Najafi,Sheyda
Heidari,Kazem
Javadi,Mohammad R.
Hadjibabaie,Molouk
Gholami,Kheirollah
A community pharmacy-based cardiovascular risk screening service implemented in Iran
author_facet Jahangard-Rafsanjani,Zahra
Hakimzadeh,Negar
Sarayani,Amir
Najafi,Sheyda
Heidari,Kazem
Javadi,Mohammad R.
Hadjibabaie,Molouk
Gholami,Kheirollah
author_sort Jahangard-Rafsanjani,Zahra
title A community pharmacy-based cardiovascular risk screening service implemented in Iran
title_short A community pharmacy-based cardiovascular risk screening service implemented in Iran
title_full A community pharmacy-based cardiovascular risk screening service implemented in Iran
title_fullStr A community pharmacy-based cardiovascular risk screening service implemented in Iran
title_full_unstemmed A community pharmacy-based cardiovascular risk screening service implemented in Iran
title_sort community pharmacy-based cardiovascular risk screening service implemented in iran
description Abstract Background: Cardiovascular disease is a major health concern around the world. Objective: To assess the outcomes and feasibility of a pharmacy-based cardiovascular screening in an urban referral community pharmacy in Iran. Methods: A cross sectional study was conducted in a referral community pharmacy. Subjects aged between 30-75 years without previous diagnose of cardiovascular disease or diabetes were screened. Measurement of all major cardiovascular risk factors, exercise habits, medical conditions, medications, and family history were investigated. Framingham risk score was calculated and high risk individuals were given a clinical summary sheet signed by a clinical pharmacist and were encouraged to follow up with their physician. Subjects were contacted one month after the recruitment period and their adherence to the follow up recommendation was recorded. Results: Data from 287 participants were analyzed and 146 were referred due to at least one abnormal laboratory test. The results showed 26 patients with cardiovascular disease risk greater than 20%, 32 high systolic blood pressure, 22 high diastolic blood pressures, 50 high total cholesterol levels, 108 low HDL-C levels, and 22 abnormal blood glucose levels. Approximately half of the individuals who received a follow up recommendation had made an appointment with their physician. Overall, 15.9% of the individuals received medications and 15.9% received appropriate advice for risk factor modification. Moreover, 7.5% were under evaluation by a physician. Conclusion: A screening program in a community pharmacy has the potential to identify patients with elevated cardiovascular risk factor. A plan for increased patient adherence to follow up recommendations is required.
publisher Centro de Investigaciones y Publicaciones Farmacéuticas
publishDate 2017
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2017000200006
work_keys_str_mv AT jahangardrafsanjanizahra acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT hakimzadehnegar acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT sarayaniamir acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT najafisheyda acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT heidarikazem acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT javadimohammadr acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT hadjibabaiemolouk acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT gholamikheirollah acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT jahangardrafsanjanizahra communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT hakimzadehnegar communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT sarayaniamir communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT najafisheyda communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT heidarikazem communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT javadimohammadr communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT hadjibabaiemolouk communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
AT gholamikheirollah communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran
_version_ 1755999639564189696